| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print November 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 6, 2002
Medicine Dept., Julia-McFarlane Diabetes Center, The University of Calgary, Calgary, AB T2N 4N1
Corresponding Author: dcwlau{at}ucalgary.ca
Cyclooxygenase (COX) catalyses the rate limiting step of prostanoid biosynthesis. Two COX isoforms have been identified, COX-1, the constitutive form, and COX-2, the inducible form. While COX-2 has been implicated in body fat regulation, the underlying cellular mechanism remains to be elucidated. The present study was undertaken to examine the potential role of COX in modulating adipogenesis and to dissect the relative contribution of the two isoenzymes in this process. COX-2 was found to be expressed in undifferentiated 3T3-L1 cells and down-regulated during differentiation, whereas the cellular level of COX-1 remained relatively constant. Abrogating the activity of either of these two isoenzymes by selective COX inhibitors accelerated cellular differentiation, suggesting that both COX isoenzymes negatively influenced differentiation. Tumor necrosis factor-a (TNFa) significantly up-regulated COX-2 expression (~2 fold) in differentiating 3T3-L1 cells, whereas similar effect was not observed with COX-1 expression. Abrogating the induced COX-2 activity reversed the TNFa-induced inhibition of differentiation by ~70%, implying a role for COX-2 in mediating TNFa signaling. Hence, both COX isoforms were involved in the negative modulation of adipocyte differentiation. COX-2 appeared to be the main isoform mediating at least part of the negative effects of TNFa.
Revised on October 28, 2002
Accepted on October 29, 2002
Role of cyclooxygenases, COX-1 and COX-2, in modulating adipogenesis in 3T3-L1 cells
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Dragunow, R. Cameron, P. Narayan, and S. O'Carroll Image-Based High-Throughput Quantification of Cellular Fat Accumulation J Biomol Screen, October 1, 2007; 12(7): 999 - 1005. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Tirard, J. Gout, A. M. Lefrancois-Martinez, A. Martinez, M. Begeot, and D. Naville A Novel Inhibitory Protein in Adipose Tissue, the Aldo-Keto Reductase AKR1B7: Its Role in Adipogenesis Endocrinology, May 1, 2007; 148(5): 1996 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Martin-Venegas, S. Roig-Perez, R. Ferrer, and J. J. Moreno Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation J. Lipid Res., July 1, 2006; 47(7): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Petersen, C. Jorgensen, A. C. Rustan, L. Froyland, K. Muller-Decker, G. Furstenberger, R. K. Berge, K. Kristiansen, and L. Madsen Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases J. Lipid Res., December 1, 2003; 44(12): 2320 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fajas, S. Miard, M. R. Briggs, and J. Auwerx Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase J. Lipid Res., September 1, 2003; 44(9): 1652 - 1659. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
